In this month's magazine, we offer a tantalising glance towards the future of medicine in On target? (p28), where we deep-dive into the exciting world of precision medicine. In Higher education (p32), we chart the evolution of medical education, asking what role pharma should play in this era of mistrust, millennials and meagre resources. In SmartViews, we offer an in-depth look at one of the NHS' shiniest new toys, Vanguards (On the front line, p17), ask questions about whether driving down cost is the best way to procure high-quality services (Under the hammer, p19) and explore the brave new world of online communities (Community spirit, p22). Also in this issue, we profile an award-winning young marketer about emerging trends (New to the market, p38) and interview entrepreneurial Cambridge professor Tony Kouzarides (Building blocks, p40).
Pharma-sponsored medical education has always been about much more than just education, yet with greater transparency, changing learning styles and increased influence of expert patients, what does the future hold for pharma's wider interactions with healthcare professionals?